Depression and Anxiety in Rheumatoid Arthritis

The primary endpoint of this study is to evaluate the prevalence of anxiety and depressive disorders, and their relationship with disease activity, in patients with rheumatoid arthritis treated with biological drugs

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Anxiety Anxiety Disorders Arthritis Arthritis, Rheumatoid Autoimmune Diseases Behavior Behavioral Symptoms Connective Tissue Diseases Depression Immune System Diseases Joint Diseases Mental Disorders Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS policlinico San Matteo - Reparto di Reumatologia

Pavia, PV, 27100, Italy

About this study

The prevalence of anxiety and depressive disorders will be assesed with the HADS questionnaire at the time of the visit

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age >18 years
diagnosis of rheumatoid arthritis according to 2010 Classification American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) Criteria
being able to compile questionnaire
current treatment with biological disease-modifying antirheumatic drug

Exclusion criteria

Current treatment for anxiety or depressive disorder

Treatment and study plan

Hospital Anxiety and Depression Scale (HADS) questionnaire

Other

Patients filled in the Hospital Anxiety and Depression Scale (HADS) questionnaire

Primary outcomes

Hospital Anxiety and Depression Scale (HADS)

Time frame: 1 day of enrollement

Hospital Anxiety and Depression Scale (HADS) questionnaire. The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Registry information

Official study title

Depression and Anxiety in Rheumatoid Arthritis: Prevalence and Relation With Disease Activity

Acronym: DEAR

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Apr 24, 2014
Registry last updated: Oct 10, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed